Ethyl (13E,15S)-1-ethoxy-15-hydroxy-5-methyl-1,9-dioxoprost-13-ene-8-carboxylate, with CAS number 62151-21-7, is a synthetic compound belonging to the class of prostaglandin analogs. This substance is characterized by its complex molecular structure, which includes multiple functional groups such as an ethoxy group, hydroxyl group, and carboxylate. The presence of dioxo and alkene functionalities contributes to its reactivity and potential biological activity. Typically, compounds of this nature are studied for their pharmacological properties, particularly in relation to their effects on the cardiovascular system and reproductive health. The stereochemistry indicated by the (13E,15S) notation suggests specific spatial arrangements of atoms that can influence the compound's interaction with biological targets. As with many prostaglandin derivatives, this compound may exhibit a range of physiological effects, including modulation of inflammation and regulation of smooth muscle contraction. Its solubility, stability, and bioavailability are critical factors that influence its application in medicinal chemistry and therapeutic development.

HR-546 is a prostaglandin E2 and prostaglandin F2alpha antagonist.

ethyl (13E,15S)-1-ethoxy-15-hydroxy-5-methyl-1,9-dioxoprost-13-ene-8-carboxylate

62151-21-7: Ethyl (13E,15S)-1-ethoxy-15-hydroxy-5-methyl-1,9-dioxoprost-13-ene-8-carboxylate, with CAS number 62151-21-7, is a synthetic compound belonging to the class of prostaglandin analogs. This substance is characterized by its complex molecular structure, which includes multiple functional groups such as an ethoxy group, hydroxyl group, and carboxylate. The presence of dioxo and alkene functionalities contributes to its reactivity and potential biological activity. Typically, compounds of this nature are studied for their pharmacological properties, particularly in relation to their effects on the cardiovascular system and reproductive health. The stereochemistry indicated by the (13E,15S) notation suggests specific spatial arrangements of atoms that can influence the compound's interaction with biological targets. As with many prostaglandin derivatives, this compound may exhibit a range of physiological effects, including modulation of inflammation and regulation of smooth muscle contraction. Its solubility, stability, and bioavailability are critical factors that influence its application in medicinal chemistry and therapeutic development.

CAS 62151-21-7

ethyl (13E,15S)-1-ethoxy-15-hydroxy-5-methyl-1,9-dioxoprost-13-ene-8-carboxylate

HR-546

Ref: TM-T68983